Currrent status and research strategies in tuberculosis drug development

Dover, Lynn G. and Coxon, Geoffrey (2011) Currrent status and research strategies in tuberculosis drug development. Journal of Medicinal Chemistry, 54 (18). 6157–6165. ISSN 0022-2623

Abstract

In this Miniperspective we broadly cover the recent developments and strategies that are being adopted globally in the battle to urgently discover and develop new drugs to treat tuberculosis (TB). It highlights the impact and outcomes of recent nongovernment organizations (NGO) and academic research consortia that have made a significant impact in recent years in the field, providing the reader with an insight into the overall status of TB drug discovery and development while illustrating the current strategies and directions that are currently being adopted to find new drugs to control the disease.

ORCID iDs

Coxon, Geoffrey ORCID: https://orcid.org/0000-0002-3541-5236

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSArchivematicaHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Citations and altmetrics
• Item metadata

  Item type:	Article
  ID code:	38938
  Dates:	Date Event 2011 Published 8 August 2011 Published Online
  Keywords:	drug discovery, drug development, tuberculosis, disease control, Therapeutics. Pharmacology, Drug Discovery, Molecular Medicine, SDG 3 - Good Health and Well-being
  Subjects:	Medicine > Therapeutics. Pharmacology
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	04 Apr 2012 10:26
  Last modified:	15 Sep 2021 16:46
  Related URLs:	Scopus publication
  URI:	https://strathprints.strath.ac.uk/id/eprint/38938